Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-07-27 5:15 pm Sale | 2023-07-17 | 13D | Neoleukin Therapeutics, Inc. NLTX | Redmile Group, LLC | 145,611 6.600% | -5,917 (-3.90%) | Filing History |
| 2023-06-28 5:15 pm Purchase | 2023-06-26 | 13D | IGM Biosciences, Inc. IGMS | Redmile Group, LLC | 3,291,092 9.900% | 257,595 (+8.49%) | Filing History |
| 2023-06-21 5:15 pm Purchase | 2023-06-16 | 13D | MedAvail Holdings, Inc. MDVL | Redmile Group, LLC | 2,490,145 73.100% | 1,306,257 (+110.34%) | Filing History |
| 2023-06-15 5:15 pm Unchanged | 2023-06-13 | 13D | Augmedix, Inc. AUGX | Redmile Group, LLC | 20,246,320 44.700% | 0 (Unchanged) | Filing History |
| 2023-06-13 5:15 pm Sale | 2023-06-12 | 13D | IGM Biosciences, Inc. IGMS | Redmile Group, LLC | 3,033,497 10.300% | -343,593 (-10.17%) | Filing History |
| 2023-05-04 5:15 pm Unchanged | 2023-05-02 | 13D | Augmedix, Inc. AUGX | Redmile Group, LLC | 20,246,320 44.700% | 0 (Unchanged) | Filing History |
| 2023-04-21 5:15 pm Purchase | 2023-04-14 | 13D | Augmedix, Inc. AUGX | Redmile Group, LLC | 20,246,320 44.700% | 4,375,195 (+27.57%) | Filing History |
| 2023-04-19 5:15 pm Purchase | 2023-04-13 | 13D | Fate Therapeutics, Inc. FATE | Redmile Group, LLC | 15,071,096 14.900% | 2,077,208 (+15.99%) | Filing History |
| 2023-03-14 5:32 pm Purchase | 2023-03-09 | 13D | MedAvail Holdings, Inc. MDVL | Redmile Group, LLC | 1,183,888 56.500% | 250,405 (+26.82%) | Filing History |
| 2023-02-14 4:32 pm Sale | 2022-12-31 | 13G | Stereotaxis, Inc. STXS | Redmile Group, LLC | 7,097,616 8.800% | -210,709 (-2.88%) | Filing History |
| 2023-02-14 4:32 pm Sale | 2022-12-31 | 13G | Scholar Rock Holding Corporation SRRK | Redmile Group, LLC | 5,501,389 9.900% | -29,611 (-0.54%) | Filing History |
| 2023-02-14 4:31 pm Purchase | 2022-12-31 | 13G | HOOKIPA Pharma Inc. HOOK | Redmile Group, LLC | 546,077 9.900% | 268,863 (+96.99%) | Filing History |
| 2023-02-14 4:29 pm Sale | 2022-12-31 | 13G | Achilles Therapeutics plc ACHL | Redmile Group, LLC | 1,608,089 3.900% | -480,000 (-22.99%) | Filing History |
| 2023-02-14 4:29 pm Purchase | 2022-12-31 | 13G | Zymeworks Inc. ZYME | Redmile Group, LLC | 6,175,918 9.800% | 100,000 (+1.65%) | Filing History |
| 2023-02-14 4:29 pm Sale | 2022-12-31 | 13G | Repare Therapeutics Inc. RPTX | Redmile Group, LLC | 2,684,396 6.400% | -105,100 (-3.77%) | Filing History |
| 2023-02-14 4:28 pm Purchase | 2022-12-31 | 13G | Pliant Therapeutics, Inc. PLRX | Redmile Group, LLC | 3,878,599 8.000% | 795,098 (+25.79%) | Filing History |
| 2023-02-14 4:27 pm Purchase | 2022-12-31 | 13G | Kymera Therapeutics, Inc. KYMR | Redmile Group, LLC | 2,673,837 4.900% | 86,107 (+3.33%) | Filing History |
| 2023-02-14 4:27 pm Purchase | 2022-12-31 | 13G | Krystal Biotech, Inc. KRYS | Redmile Group, LLC | 1,896,645 7.400% | 75,747 (+4.16%) | Filing History |
| 2023-02-14 4:25 pm Sale | 2022-12-31 | 13G | Entrada Therapeutics, Inc. TRDA | Redmile Group, LLC | 1,854,108 5.900% | -100,312 (-5.13%) | Filing History |
| 2023-02-14 4:23 pm Purchase | 2022-12-31 | 13G | Akero Therapeutics, Inc. AKRO | Redmile Group, LLC | 2,632,912 5.600% | 1,030,627 (+64.32%) | Filing History |